PDF to PPT Converter From Presentations.AI Turns PDFs Into Editable PowerPoint Slide Decks With AI, Keeping Charts, Tables and Images Intact, as a Free-to-Try Gamma and Beautiful.ai Alternative 
Hong Kong Autumn Electronics Fair and electronicAsia attract over 61,000 buyers for sourcing, business opportunities 
Cotecna Group Acquires Energon Labs, Strengthening Global Pharmaceutical Testing Capabilities and Expanding its Presence in India HKTDC Education & Careers Expo opens on 21 July
HONG KONG, Jul 12, 2022 – (ACN Newswire) – Organised by the Hong Kong Trade…
Redgate survey identifies key database monitoring challenges businesses should focus on in fast-growing Financial Services sector
A sector analysis of the results from a major database monitoring survey has revealed how…
CohBar Appoints Effie Tozzo, Ph.D. to Its Board of Directors
MENLO PARK, Calif., July 12, 2022 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR), a clinical…
AXIM Biotechnologies Publishes Study Highlighting Neutralizing Antibody Levels of Poor Vaccine Responders with a Third COVID-19 Vaccine Dose
SAN DIEGO, July 12, 2022 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc (OTCQB: AXIM) (“AXIM Biotech,”…
Y-mAbs’ Announces Clearance of IND for GD2-SADA
NEW YORK, July 12, 2022 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
OmniPathology Announces the Launch of its Oropharyngeal HPV PCR Test
New oropharyngeal Human Papillomavirus (HPV) PCR test helps screen for oropharyngeal cancer and detection of…
Ceapro Bolsters Executive Management Team with Appointment of Sigrun Watson as Chief Revenue Officer
Recognized commercial leader with over 20 years of experience across diverse healthcare industries Appointment marks…
Allogene Therapeutics Appoints Scientific Pioneer Stephen Mayo to its Board of Directors
SOUTH SAN FRANCISCO, Calif., July 12, 2022 (GLOBE NEWSWIRE) — Allogene Therapeutics, Inc. (Nasdaq: ALLO),…
Bioventus Completes CartiHeal Acquisition
DURHAM, N.C., July 12, 2022 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the…
Accelus Announces Series D Equity Financing Led by Concord Health Partners (CHP
• CHP Co-Founder and Partner Joseph Swedish Named to Accelus Board of Directors PALM BEACH…
NAPIGEN Completes $7.85 Million Funding Round to Advance Its Mitochondrial and Chloroplast Gene Editing Technology
Funds will be used to develop hybrid seed technology in wheat and rice through gene…
BioCardia to Participate in Upcoming Heart and Pulmonary Therapy Development Symposia
SUNNYVALE, Calif., July 12, 2022 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], Sunnyvale, Calif. – BioCardia®, Inc. [Nasdaq: BCDA],…
Akoya to Report Second Quarter 2022 Financial Results on August 8th, 2022
MARLBOROUGH, Mass., July 12, 2022 (GLOBE NEWSWIRE) — Akoya Biosciences, Inc. (Nasdaq: AKYA) (“Akoya”), The…
Agile Therapeutics Updates Second Quarter 2022 Guidance
Twirla® Demand Guidance (Total Cycles) Expected to be at Midpoint of Guided Range Operating Expenses…
Reflect Scientific Inc Second Quarter Shareholder Letter
OREM, Utah, July 12, 2022 (GLOBE NEWSWIRE) — Reflect Scientific, Inc. (Symbol: RSCF), a provider…
scPharmaceuticals Inc. Announces Positive Results from the AT HOME-HF Phase 2 Pilot Study in Heart Failure
Study results favor FUROSCIX®versus “treatment as usual” in composite primary endpoint and all secondary endpoints…
IN8bio Appoints Kenneth R. LaMontagne, Ph.D., to Lead Business Development
NEW YORK, July 12, 2022 (GLOBE NEWSWIRE) — IN8bio, Inc. (Nasdaq: INAB), a clinical-stage biopharmaceutical…
Recce Pharmaceuticals Appoints Philip Sutton, Ph.D., as Vice President of Translational Sciences
– Dr. Sutton to help advance Recce’s portfolio of infectious disease programs focused on significant…
Revolutionary Chronic Kidney Disease Therapeutics Company ProKidney to List on the Nasdaq Following Business Combination with Social Capital Suvretta Holdings Corp. III
ProKidney Class A ordinary shares to begin trading on Nasdaq under the ticker symbol “PROK”…
Certara to Report Second Quarter 2022 Financial Results on August 9th, 2022
PRINCETON, N.J., July 12, 2022 (GLOBE NEWSWIRE) — Certara, Inc. (Nasdaq: CERT), a global leader…